Hossini AM - Search Results

1

A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.

Hossini AM, Geilen CC, Fecker LF, Daniel PT, Eberle J. Hossini AM, et al. Oncogene. 2006 Apr 6;25(15):2160-9. doi: 10.1038/sj.onc.1209253. Oncogene. 2006. PMID: 16288206

2

The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.

Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC. Raisova M, et al. Among authors: hossini am. J Invest Dermatol. 2001 Aug;117(2):333-40. doi: 10.1046/j.0022-202x.2001.01409.x. J Invest Dermatol. 2001. PMID: 11511312 Free article.

3

Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.

Raisova M, Goltz G, Bektas M, Bielawska A, Riebeling C, Hossini AM, Eberle J, Hannun YA, Orfanos CE, Geilen CC. Raisova M, et al. Among authors: hossini am. FEBS Lett. 2002 Apr 10;516(1-3):47-52. doi: 10.1016/s0014-5793(02)02472-9. FEBS Lett. 2002. PMID: 11959101 Free article.

4

The role of nuclear factor-kappa B and melanogenesis in tumor necrosis factor-alpha-induced apoptosis of normal human melanocytes.

Shang J, Eberle J, Geilen CC, Hossini AM, Fecker LF, Orfanos CE, Tebbe B. Shang J, et al. Among authors: hossini am. Skin Pharmacol Appl Skin Physiol. 2002 Sep-Oct;15(5):321-9. doi: 10.1159/000064536. Skin Pharmacol Appl Skin Physiol. 2002. PMID: 12239426

5

Conditional expression of exogenous Bcl-X(S) triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts.

Hossini AM, Eberle J, Fecker LF, Orfanos CE, Geilen CC. Hossini AM, et al. FEBS Lett. 2003 Oct 23;553(3):250-6. doi: 10.1016/s0014-5793(03)01017-2. FEBS Lett. 2003. PMID: 14572633 Free article.

6

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.

Eberle J, Fecker LF, Hossini AM, Wieder T, Daniel PT, Orfanos CE, Geilen CC. Eberle J, et al. Among authors: hossini am. Oncogene. 2003 Dec 11;22(57):9131-41. doi: 10.1038/sj.onc.1207228. Oncogene. 2003. PMID: 14668794

7

Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.

Fecker LF, Geilen CC, Hossini AM, Schwarz C, Fechner H, Bartlett DL, Orfanos CE, Eberle J. Fecker LF, et al. Among authors: hossini am. J Invest Dermatol. 2005 Jan;124(1):221-8. doi: 10.1111/j.0022-202X.2004.23572.x. J Invest Dermatol. 2005. PMID: 15654977 Free article.

8

Effect of 5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal papilla cells.

Winiarska A, Mandt N, Kamp H, Hossini A, Seltmann H, Zouboulis CC, Blume-Peytavi U. Winiarska A, et al. Skin Pharmacol Physiol. 2006;19(6):311-21. doi: 10.1159/000095251. Epub 2006 Aug 23. Skin Pharmacol Physiol. 2006. PMID: 16931898

9

Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.

Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF. Eberle J, et al. Among authors: hossini am. Drug Resist Updat. 2007 Dec;10(6):218-34. doi: 10.1016/j.drup.2007.09.001. Epub 2007 Dec 3. Drug Resist Updat. 2007. PMID: 18054518 Review.

10

Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma.

Eberle J, Fecker LF, Hossini AM, Kurbanov BM, Fechner H. Eberle J, et al. Among authors: hossini am. Exp Dermatol. 2008 Jan;17(1):1-11. doi: 10.1111/j.1600-0625.2007.00655.x. Exp Dermatol. 2008. PMID: 18095940 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters